Author

Mingjun Zhang

Observed names: M Zhang, M. Zhang

Institutions: Qingdao University, Anhui Medical University, Yuhuangding Hospital, Peking University Cancer Hospital, Second Affiliated Hospital of Anhui Medical University

Observed institutions: Qingdao University, Anhui Medical University, Yuhuangding Hospital, Zhengzhou University, Peking University Cancer Hospital, Second Affiliated Hospital of Anhui Medical University

ORCID: 0009-0007-2493-5141

Observed ORCID: 0009-0007-2493-5141

OpenAlex ID: A5055469842

Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial

2025 · Yinghong Shi, Guohong Han, et al. · The Lancet. Gastroenterology & hepatology · 51

Disitamab vedotin (DV) plus toripalimab (Tor) and chemotherapy (C)/trastuzumab (Tra) as first-line (1L) treatment of patients (pts) with HER2-expressing locally advanced or metastatic (la/m) gastric cancer.

2025 · Lin Shen, Zhi Peng, et al. · Journal of Clinical Oncology · 9

Sacituzumab tirumotecan in participants with advanced or metastatic urothelial carcinoma and disease progression after chemotherapy and immune checkpoint inhibitors

2025 · Y. Zhu, S. Jiang, et al. · Annals of Oncology · 7

[Research progression in neural invasion model of pancreatic cancer].

2020 · G H You, Y J Wang, et al. · PubMed · 3

Identification of a Prognostic Signature Based on Tumor‐Infiltrating B Lymphocyte mRNA in Head and Neck Squamous Cell Carcinoma

2025 · Mingjun Zhang, Qi Sun, et al. · Journal of Immunology Research · 2

IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with HER2-positive breast cancer (BC) and other solid tumors: Updates from a phase 1 study.

2025 · Charlotte Rose Lemech, Yuping Sun, et al. · Journal of Clinical Oncology · 1

Abstract LB212: Efficacy and safety of JS015 (an anti-dickkopf-1 antibody) in combination with standard of care in patients with gastrointestinal cancers

2025 · Yong Gao, Ming Quan, et al. · Cancer Research · 1

[Effects of LINC00839 targeting miR-3666 on proliferation, migration and invasion of hepatocellular carcinoma cells].

2021 · B Meng, F Han, et al. · PubMed · 1

[Cost-effectiveness of anti-tumor associated antigen autoantibody screening for hepatocellular carcinoma in the population with chronic hepatitis B-related cirrhosis].

2021 · M Zhang, Y G Li, et al. · PubMed · 1

Initial results from a phase I study of the SHP2 inhibitor GH21 as monotherapy in patients with advanced solid tumors.

2025 · Miao Zhang, Lin Shen, et al. · Journal of Clinical Oncology

First-line QL1706 plus carboplatin and etoposide in patients with extensive-stage small cell lung cancer: an open-label, single-arm, phase 2 trial

2025 · Zhehai Wang, Yun Fan, et al. · SSRN Electronic Journal

Works count: 11

Citation count: 76

H-index: 3

I10-index: 1